Similar Posts
Politics And The Markets 01/03/25
This is the forum for daily political discussion on Seeking Alpha. A new version is published every market day. Please don’t leave political comments on other articles or posts on the site. The comments below are not regulated with the same rigor as the rest of the site, and this is an ‘enter at your…
CoreLogic: US Home Prices Increased 3.4% Year-over-year in September, “Slowest growth rate in over a year”
by Calculated Risk on 11/05/2024 02:19:00 PM Notes: This CoreLogic House Price Index report is for September. The recent Case-Shiller index release was for August. The CoreLogic HPI is a three-month weighted average and is not seasonally adjusted (NSA). From CoreLogic: CoreLogic: Annual Home Price Slowdown Continues in September • On an annual basis, home…
M&M outpaces industry with 10.5% Q1 growth, gains market share across segments, says Siddhartha Khemka
India’s tractor industry posted a healthy 9.2% YoY growth in Q1FY26, delivering 2.86 lakh units, driven by robust demand in the high-horsepower (HP) categories and pre-season stocking ahead of the Kharif sowing period. Favourable Rabi harvest earnings and steady demand from key agricultural states underpinned the strong start to the fiscal year. The 41–50HP segment…
What are ETFs?
Skip to content Exchange-Traded Funds (ETFs) are investment funds that trade on stock exchanges, like individual stocks. They offer a way to invest in a diversified portfolio of assets, including stocks, bonds, commodities, and other securities. ETFs are known for their flexibility and liquidity, as they can be bought or sold throughout the trading day…
S&P 500: An End In Sight (Technical Analysis) (SP500)
S&P 500: An End In Sight (Technical Analysis) Source link
Geron Corporation: FDA Approval Fuels Stock Price Surge
$4.59 +0.70 (+17.99%) (As of 06/7/2024 ET) 52-Week Range $1.64 ▼ $5.15 Price Target $6.10 The recent FDA approval of RYTELO™ (imetelstat) has propelled Geron Corporation NASDAQ: GERN into the spotlight, sparking a surge in Geron’s stock price and attracting heightened attention from investors seeking opportunities within the healthcare sector and biotech sector. This momentous achievement…
